Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DNX Biopharmaceuticals

DNX Biopharmaceuticals
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE (Cancelled)
1 INVESTORS
Description

Owner and operator of a biopharmaceutical company intended to develop long-acting therapeutic proteins for the treatment of patients with life-long diseases. The company's biopharmaceutical services focus on development of new therapeutic proteins utilizing a half-life extension platform that produces therapeutic proteins and biological drugs to treat auto-inflammatory diseases, enabling medical researchers to facilitate treatment of rheumatoid arthritis and other related diseases, while off-setting the development cost through therapeutic proteins and biological drugs.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 19800 MacArthur Boulevard
  • Suite 300
  • Irvine, CA 92612
  • United States

+1 (949) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore DNX Biopharmaceuticals’s full profile, request a free trial.

DNX Biopharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 01-Jul-2016 Cancelled Startup
1. Accelerator/Incubator 14-May-2016 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

DNX Biopharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
EvoNexus Accelerator/Incubator 000 0000 000000 0

DNX Biopharmaceuticals Executive Team (5)

Name Title Board
Seat
Contact
Info
Rajiv Datar Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Claude Gingras Chief Financial Officer & Chief Compliance Officer
Scott Brown Ph.D Chief Technology Officer
Jeff Hale Chief Business Officer
John Caputo Co-Founder & Board Member

DNX Biopharmaceuticals Board Members (5)

Name Representing Role Since Contact
Info
Howard Levine Ph.D Self Co-Founder & Board Member 000 0000
John Caputo DNX Biopharmaceuticals Co-Founder & Board Member 000 0000
Rajiv Datar Ph.D DNX Biopharmaceuticals Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Thomas Zindrick JD DNX Biopharmaceuticals Board Member 000 0000

1 Former Board Member

You’re viewing 4 of 5 board members. Get the full list »